SIRT3 and breast carcinoma: Since numerous data postulate that an increase in ROS generated after exposure to E2 contributes to the development of human breast cancer [50,51], our findings propose that Sirt3 can function as a tumor suppressor by activating antioxidative enzymes and attenuating the E2-induced ROS levels from both cytosolic and mitochondrial compartments.